Robert Cornell, MD
Hematology · Nashville, TNNPI 1619199486
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,847 of the $16,887 with a category attached, or 82.0%. 7 manufacturers reported payments, led by Sanofi at 28.0% of the total. Reporting peaked in 2019 at $12,012 and has fallen 99.3% since, to $80 in 2024.
Across 26 payments — averaging $649.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$5K
- Janssen Research & Development, LLC$4K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- GSK$2K
- Pfizer$2K
- AbbVie$1K
- plus $74 from 1 others
Across 87 payments — averaging $22,685 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$1M
- Ichnos Glenmark Innovation Inc$387K
- GSK$242K
- Janssen Research & Development, LLC$224K
- Pharmacyclics LLC, An Abbvie Company$54K
- Takeda Pharmaceuticals U.S.A., Inc.$42K
- plus $16K from 1 others
What the payments were for
- Consulting fees$13,84782%
- Speaking & faculty fees$1,2708%
- Travel & lodging$1,0516%
- Food & beverage$6384%
- Education$800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 1 | $4,732 |
| Janssen Research & Development, LLC | 2 | $4,200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $2,728 |
| GSK | 8 | $2,462 |
| Pfizer | 6 | $1,621 |
| AbbVie | 6 | $1,070 |
| Gilead | 1 | $74 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,887 in reported general payments places this provider in the 65th percentile of 23 hematology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Nashville
- Stephen StricklandNashville$120K
- Michael SavonaNashville$100K
- Ashwin KishtagariNashville$88K
- Navneet MajhailNashville$58K
- Adetola KassimNashville$26K
- Michael ByrneNashville$18K
- Anne NeffNashville$5K
- Silvia BuntingNashville$4K
- Wesam AhmedNashville$4K
- Phyu Thin NaingNashville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.